
T2 Biosystems TTOO
Quartalsbericht 2024-Q3
hinzugefügt 14.11.2024
T2 Biosystems DIO 2011-2026 | TTOO
DIO Jährlich T2 Biosystems
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 71.2 | - | 62.4 | 78.4 | 63.4 | 40.8 | 42.7 | 143 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 143 | 40.8 | 71.7 |
DIO anderer Aktien in der Diagnostik & Forschung
| Name | DIO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
32.2 | - | -6.19 % | $ 10.5 M | ||
|
Agilent Technologies
A
|
97.1 | $ 117.79 | 3.44 % | $ 35.8 B | ||
|
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
48.7 | $ 25.76 | 3.75 % | $ 716 M | ||
|
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | ||
|
Danaher Corporation
DHR
|
87.6 | $ 197.13 | 3.2 % | $ 140 B | ||
|
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
60.9 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
7.17 | $ 16.46 | 3.46 % | $ 498 M | ||
|
CareDx, Inc
CDNA
|
48.3 | $ 18.77 | 6.23 % | $ 1 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
82.1 | $ 98.12 | 5.17 % | $ 12.3 B | ||
|
DexCom
DXCM
|
115 | $ 65.04 | 3.05 % | $ 25.4 B | ||
|
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | ||
|
Burning Rock Biotech Limited
BNR
|
243 | $ 16.49 | 2.49 % | $ 177 M | ||
|
Co-Diagnostics
CODX
|
1.69 K | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
ICON Public Limited Company
ICLR
|
0.213 | $ 111.47 | 4.02 % | $ 9.19 B | ||
|
Illumina
ILMN
|
137 | $ 131.01 | 3.61 % | $ 20.8 B | ||
|
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | ||
|
Laboratory Corporation of America Holdings
LH
|
18.9 | $ 272.99 | 1.42 % | $ 22.7 B | ||
|
Lantheus Holdings
LNTH
|
40.4 | $ 79.33 | 1.6 % | $ 5.35 B | ||
|
Charles River Laboratories International
CRL
|
35.3 | $ 178.81 | 5.42 % | $ 8.86 B | ||
|
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
79 | $ 1 314.35 | 3.49 % | $ 27.1 B | ||
|
Myriad Genetics
MYGN
|
42.8 | $ 4.91 | 3.61 % | $ 455 M | ||
|
NeoGenomics
NEO
|
24.4 | $ 8.46 | 4.96 % | $ 1.08 B | ||
|
Neogen Corporation
NEOG
|
147 | $ 10.59 | 6.06 % | $ 2.3 B | ||
|
OpGen
OPGN
|
459 | - | -16.95 % | $ 1.54 M | ||
|
Natera
NTRA
|
25.8 | $ 217.44 | 3.9 % | $ 21.4 B | ||
|
Pacific Biosciences of California
PACB
|
173 | $ 1.53 | 6.25 % | $ 459 M | ||
|
PerkinElmer
PKI
|
87.6 | - | -0.91 % | $ 14.7 B | ||
|
Quotient Limited
QTNT
|
386 | - | -11.32 % | $ 1.1 M | ||
|
Precipio
PRPO
|
22.7 | $ 28.84 | 1.19 % | $ 46.3 M | ||
|
Personalis
PSNL
|
12.1 | $ 6.72 | 8.91 % | $ 398 M | ||
|
QIAGEN N.V.
QGEN
|
141 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
147 | $ 2.18 | 0.93 % | $ 5.01 M | ||
|
BioNano Genomics
BNGO
|
251 | $ 1.16 | -0.85 % | $ 6.32 M | ||
|
Interpace Biosciences
IDXG
|
29.1 | $ 2.0 | 1.27 % | $ 8.85 M |